Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis

被引:24
作者
Duan, Shanshan [1 ,2 ]
Moro, Loredana [1 ,2 ]
Qu, Rui [1 ,2 ]
Simoneschi, Daniele [1 ,2 ]
Cho, Hyunwoo [1 ,2 ]
Jiang, Shaowen [1 ,2 ]
Zhao, Huiyong [3 ]
Chang, Qing [3 ]
de Stanchina, Elisa [3 ]
Arbini, Arnaldo A. [2 ,4 ]
Pagano, Michele [1 ,2 ,5 ]
机构
[1] NYU, Alexandria Ctr Life Sci, Dept Biochem & Mol Pharmacol, Grossman Sch Med, New York, NY 10016 USA
[2] NYU, Alexandria Ctr Life Sci, Laura & Isaac Perlmutter Canc Ctr, Grossman Sch Med, New York, NY 10016 USA
[3] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA
[4] NYU, Alexandria Ctr Life Sci, Dept Pathol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA
[5] NYU, Alexandria Ctr Life Sci, Howard Hughes Med Inst, Grossman Sch Med, New York, NY 10016 USA
关键词
NEGATIVE-FEEDBACK-REGULATION; F-BOX PROTEINS; CELL-LINES; CANCER; SPECIFICITY; KINASE; PHOSPHATASE; ACTIVATION; UBIQUITIN; FBXO31;
D O I
10.1016/j.celrep.2021.109870
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FBXO31 is the substrate receptor of one of many CUL1-RING ubiquitin ligase (CRL1) complexes. Here, we show that low FBXO31 mRNA levels are associated with high pre-operative prostate-specific antigen (PSA) levels and Gleason grade in human prostate cancer. Mechanistically, the ubiquitin ligase CRL1FBXO31 promotes the ubiquitylation-mediated degradation of DUSP6, a dual specificity phosphatase that dephosphorylates and inactivates the extracellular-signal-regulated kinase-1 and -2 (ERK1/2). Depletion of FBXO31 stabilizes DUSP6, suppresses ERK signaling, and activates the PI3K-AKT signaling cascade. Moreover, deletion of FBXO31 promotes tumor development in a mouse orthotopic model of prostate cancer. Treatment with BCI, a small molecule inhibitor of DUSP6, suppresses AKT activation and prevents tumor formation, suggesting that the FBXO31 tumor suppressor activity is dependent on DUSP6. Taken together, our studies highlight the relevance of the FBXO31-DUSP6 axis in the regulation of ERK- and PI3K-AKT-mediated signaling pathways, as well as its therapeutic potential in prostate cancer.
引用
收藏
页数:16
相关论文
共 74 条
[1]   A module of negative feedback regulators defines growth factor signaling [J].
Amit, Ido ;
Citri, Ami ;
Shay, Tal ;
Lu, Yiling ;
Katz, Menachem ;
Zhang, Fan ;
Tarcic, Gabi ;
Siwak, Doris ;
Lahad, John ;
Jacob-Hirsch, Jasmine ;
Amariglio, Ninette ;
Vaisman, Nora ;
Segal, Eran ;
Rechavi, Gideon ;
Alon, Uri ;
Mills, Gordon B. ;
Domany, Eytan ;
Yarden, Yosef .
NATURE GENETICS, 2007, 39 (04) :503-512
[2]   Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 [J].
Bello, D ;
Webber, MM ;
Kleinman, HK ;
Wartinger, DD ;
Rhim, JS .
CARCINOGENESIS, 1997, 18 (06) :1215-1223
[3]  
Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079
[4]   The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D [J].
Chaikovsky, Andrea C. ;
Li, Chuan ;
Jeng, Edwin E. ;
Loebell, Samuel ;
Lee, Myung Chang ;
Murray, Christopher W. ;
Cheng, Ran ;
Demeter, Janos ;
Swaney, Danielle L. ;
Chen, Si-Han ;
Newton, Billy W. ;
Johnson, Jeffrey R. ;
Drainas, Alexandros P. ;
Shue, Yan Ting ;
Seoane, Jose A. ;
Srinivasan, Preethi ;
He, Andy ;
Yoshida, Akihiro ;
Hipkins, Susan Q. ;
McCrea, Edel ;
Poltorack, Carson D. ;
Krogan, Nevan J. ;
Diehl, J. Alan ;
Kong, Christina ;
Jackson, Peter K. ;
Curtis, Christina ;
Petrov, Dmitri A. ;
Bassik, Michael C. ;
Winslow, Monte M. ;
Sage, Julien .
NATURE, 2021, 592 (7856) :794-+
[5]   Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: A mechanism of tamoxifen resistance [J].
Cui, Yukun ;
Parra, Irma ;
Zhang, Mao ;
Hilsenbeck, Susan G. ;
Tsimelzon, Anna ;
Furukawa, Toru ;
Horii, Akira ;
Zhang, Zhong-Yin ;
Nicholson, Robert I. ;
Fuqua, Suzanne A. W. .
CANCER RESEARCH, 2006, 66 (11) :5950-5959
[6]   DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells [J].
Degl'Innocenti, Debora ;
Romeo, Paola ;
Tarantino, Eva ;
Sensi, Marialuisa ;
Cassinelli, Giuliana ;
Catalano, Veronica ;
Lanzi, Cinzia ;
Perrone, Federica ;
Pilotti, Silvana ;
Seregni, Ettore ;
Pierotti, Marco A. ;
Greco, Angela ;
Borrello, Maria Grazia .
ENDOCRINE-RELATED CANCER, 2013, 20 (01) :23-37
[7]   FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas [J].
Duan, Shanshan ;
Cermak, Lukas ;
Pagan, Julia K. ;
Rossi, Mario ;
Martinengo, Cinzia ;
di Celle, Paola Francia ;
Chapuy, Bjoern ;
Shipp, Margaret ;
Chiarle, Roberto ;
Pagano, Michele .
NATURE, 2012, 481 (7379) :90-U100
[8]   Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter [J].
Ekerot, Maria ;
Stavridis, Marios P. ;
Delavaine, Laurent ;
Mitchell, Michael P. ;
Staples, Christopher ;
Owens, David M. ;
Keenan, Iain D. ;
Dickinson, Robin J. ;
Storey, Kate G. ;
Keyse, Stephen M. .
BIOCHEMICAL JOURNAL, 2008, 412 :287-298
[9]   Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: Structural insights into MKP-3 activation by ERK2 [J].
Farooq, A ;
Chaturvedi, G ;
Mujtaba, S ;
Plotnikova, O ;
Zeng, L ;
Dhalluin, C ;
Ashton, R ;
Zhou, MM .
MOLECULAR CELL, 2001, 7 (02) :387-399
[10]   Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies [J].
Fattore, Luigi ;
Marra, Emanuele ;
Pisanu, Maria Elena ;
Noto, Alessia ;
de Vitis, Claudia ;
Belleudi, Francesca ;
Aurisicchio, Luigi ;
Mancini, Rita ;
Torrisi, Maria Rosaria ;
Ascierto, Paolo Antonio ;
Ciliberto, Gennaro .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11